United States Alzheimer's Disease Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

1 Market Overview

1.1 Alzheimer’s Disease Drug Introduction

1.2 Market Analysis by Type

1.2.1 Donepezil

1.2.2 Memantine

1.2.3 Rivastigmine

1.3 Market Analysis by Applications

1.3.1 Early to Moderate Stages

1.3.2 Moderate to Severe Stages

1.4 Market Analysis by States

1.4.1 California Status and Prospect (2012-2022)

1.4.2 Texas Status and Prospect (2012-2022)

1.4.3 New York Status and Prospect (2012-2022)

1.4.4 Florida Status and Prospect (2012-2022)

1.4.5 Illinois Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Profile

2.1.2 Alzheimer’s Disease Drug Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Allergan News

2.2 Eisai

2.2.1 Profile

2.2.2 Alzheimer’s Disease Drug Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Eisai News

2.3 Novartis

2.3.1 Profile

2.3.2 Alzheimer’s Disease Drug Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Novartis News

2.4 Daiichi Sankyo

2.4.1 Profile

2.4.2 Alzheimer’s Disease Drug Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Daiichi Sankyo News

2.5 Merz Pharma

2.5.1 Profile

2.5.2 Alzheimer’s Disease Drug Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Merz Pharma News

2.6 Pfizer

2.6.1 Profile

2.6.2 Alzheimer’s Disease Drug Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Pfizer News

2.7 Johnson & Johnson

2.7.1 Profile

2.7.2 Alzheimer’s Disease Drug Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Johnson & Johnson News

2.8 Lundbeck.

2.8.1 Profile

2.8.2 Alzheimer’s Disease Drug Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Lundbeck. News

3 United States Alzheimer’s Disease Drug Market Competition, by Manufacturer

3.1 United States Alzheimer’s Disease Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer (2016-2017)

3.3 United States Alzheimer’s Disease Drug Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Alzheimer’s Disease Drug Manufacturer Market Share

3.4.2 Top 5 Alzheimer’s Disease Drug Manufacturer Market Share

3.5 Market Competition Trend

4 United States Alzheimer’s Disease Drug Market Analysis by States

4.1 United States Alzheimer’s Disease Drug Sales Market Share by States

4.2 United States Alzheimer’s Disease Drug Sales by States (2012-2017)

4.3 United States Alzheimer’s Disease Drug Revenue (Value) by States (2012-2017)

5 United States Market Segmentation Alzheimer’s Disease Drug by Type

5.1 United States Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 United States Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)

5.1.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)

5.2 Donepezil Sales Growth and Price

5.2.1 United States Donepezil Sales Growth (2012-2017)

5.2.2 United States Donepezil Price (2012-2017)

5.3 Memantine Sales Growth and Price

5.3.1 United States Memantine Sales Growth (2012-2017)

5.3.2 United States Memantine Price (2012-2017)

5.4 Rivastigmine Sales Growth and Price

5.4.1 United States Rivastigmine Sales Growth (2012-2017)

5.4.2 United States Rivastigmine Price (2012-2017)

6 United States Market Segmentation Alzheimer’s Disease Drug by Application

6.1 United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

6.2 Early to Moderate Stages Sales Growth (2012-2017)

6.3 Moderate to Severe Stages Sales Growth (2012-2017)

7 California Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

7.1 California Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

7.2 California Alzheimer’s Disease Drug Sales and Market Share by Type

7.3 California Alzheimer’s Disease Drug Sales by Application (2012-2017)

8 New York Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

8.1 New York Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

8.2 New York Alzheimer’s Disease Drug Sales and Market Share by Type

8.3 New York Alzheimer’s Disease Drug Sales by Application (2012-2017)

9 Texas Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

9.1 Texas Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

9.2 Texas Alzheimer’s Disease Drug Sales and Market Share by Type

9.3 Texas Alzheimer’s Disease Drug Sales by Application (2012-2017)

10 Florida Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

10.1 Florida Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

10.2 Florida Alzheimer’s Disease Drug Sales and Market Share by Type

10.3 Florida Alzheimer’s Disease Drug Sales by Application (2012-2017)

11 Illinois Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

11.1 Illinois Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

11.2 Illinois Alzheimer’s Disease Drug Sales and Market Share by Type

11.3 Illinois Alzheimer’s Disease Drug Sales by Application (2012-2017)

12 Alzheimer’s Disease Drug Market Forecast (2017-2022)

12.1 United States Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022)

12.2 Alzheimer’s Disease Drug Market Forecast by States (2017-2022)

12.3 Alzheimer’s Disease Drug Market Forecast by Type (2017-2022)

12.4 Alzheimer’s Disease Drug Market Forecast by Application (2017-2022)

13 Alzheimer’s Disease Drug Manufacturing Cost Analysis

13.1 Alzheimer’s Disease Drug Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Price Trend of Key Raw Materials

13.1.3 Key Suppliers of Raw Materials

13.1.4 Market Concentration Rate of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.2.1 Raw Materials

13.2.2 Labor Cost

13.2.3 Manufacturing Expenses

13.3 Manufacturing Process Analysis of Alzheimer’s Disease Drug

14 Industrial Chain, Sourcing Strategy and Downstream Buyers

14.1 Alzheimer’s Disease Drug Industrial Chain Analysis

14.2 Upstream Raw Materials Sourcing

14.3 Raw Materials Sources of Alzheimer’s Disease Drug Major Manufacturers in 2016

14.4 Downstream Buyers

15 Sales Channel, Distributors, Traders and Dealers

15.1 Sales Channel

15.1.1 Direct Marketing

15.1.2 Indirect Marketing

15.1.3 Marketing Channel Future Trend

15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology

17.2 Analyst Introduction

17.3 Data Source

Figure Alzheimer’s Disease Drug Picture

Table Product Specifications of Alzheimer’s Disease Drug

Figure United States Sales Market Share of Alzheimer’s Disease Drug by Types in 2016

Table Types of Alzheimer’s Disease Drug

Figure Donepezil Picture

Table Major Manufacturers of Donepezil

Figure Memantine Picture

Table Major Manufacturers of Memantine

Figure Rivastigmine Picture

Table Major Manufacturers of Rivastigmine

Table United States Alzheimer’s Disease Drug Sales Market Share by Applications in 2016

Table Applications of Alzheimer’s Disease Drug

Figure Early to Moderate Stages Picture

Figure Moderate to Severe Stages Picture

Figure California Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Texas Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure New York Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Florida Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Illinois Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Alzheimer’s Disease Drug Type and Applications

Table Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Basic Information, Manufacturing Base and Competitors

Table Eisai Alzheimer’s Disease Drug Type and Applications

Table Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Alzheimer’s Disease Drug Type and Applications

Table Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors

Table Daiichi Sankyo Alzheimer’s Disease Drug Type and Applications

Table Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merz Pharma Basic Information, Manufacturing Base and Competitors

Table Merz Pharma Alzheimer’s Disease Drug Type and Applications

Table Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Alzheimer’s Disease Drug Type and Applications

Table Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Alzheimer’s Disease Drug Type and Applications

Table Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Lundbeck. Basic Information, Manufacturing Base and Competitors

Table Lundbeck. Alzheimer’s Disease Drug Type and Applications

Table Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table United States Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)

Figure United States Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016

Figure United States Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017

Table United States Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)

Figure United States Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2015

Figure United States Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016

Table United States Alzheimer’s Disease Drug Price by Manufacturers (2016-2017)

Figure Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2016

Figure Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2017

Figure Top 5 Alzheimer’s Disease Drug Manufacturer Market Share in 2016

Figure Top 5 Alzheimer’s Disease Drug Manufacturer Market Share in 2017

Figure United States Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table United States Alzheimer’s Disease Drug Sales by States (2012-2017)

Table United States Alzheimer’s Disease Drug Sales Market Share by States (2012-2017)

Figure United States 2012 Alzheimer’s Disease Drug Sales Market Share by States

Figure United States 2016 Alzheimer’s Disease Drug Sales Market Share by States

Figure United States Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Table United States Alzheimer’s Disease Drug Revenue by States (2012-2017)

Table United States Alzheimer’s Disease Drug Revenue Market Share by States (2012-2017)

Table United States 2012 Alzheimer’s Disease Drug Revenue Market Share by States

Table United States 2016 Alzheimer’s Disease Drug Revenue Market Share by States

Table United States Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table United States Alzheimer’s Disease Drug Sales Share by Type (2012-2017)

Table United States Alzheimer’s Disease Drug Revenue by Type (2012-2017)

Table United States Alzheimer’s Disease Drug Revenue Share by Type (2012-2017)

Figure United States Donepezil Sales Growth (2012-2017)

Figure United States Donepezil Price (2012-2017)

Figure United States Memantine Sales Growth (2012-2017)

Figure United States Memantine Price (2012-2017)

Figure United States Rivastigmine Sales Growth (2012-2017)

Figure United States Rivastigmine Price (2012-2017)

Table United States Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table United States Alzheimer’s Disease Drug Sales Share by Application (2012-2017)

Figure United States Early to Moderate Stages Sales Growth (2012-2017)

Figure United States Moderate to Severe Stages Sales Growth (2012-2017)

Figure California Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure California Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table California Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table California Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table California Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table California Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Figure New York Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure New York Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table New York Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table New York Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table New York Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table New York Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Figure Texas Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure Texas Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table Texas Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table Texas Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table Texas Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table Texas Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Figure Florida Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure Florida Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table Florida Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table Florida Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table Florida Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table Florida Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Figure Illinois Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure Illinois Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table Illinois Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table Illinois Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table Illinois Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table Illinois Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Figure United States Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022)

Table United States Alzheimer’s Disease Drug Sales Forecast by States (2017-2022)

Table United States Alzheimer’s Disease Drug Market Share Forecast by States (2017-2022)

Table United States Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)

Table United States Alzheimer’s Disease Drug Market Share Forecast by Type (2017-2022)

Table United States Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)

Table United States Alzheimer’s Disease Drug Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Alzheimer’s Disease Drug

Figure Manufacturing Process Analysis of Alzheimer’s Disease Drug

Figure Alzheimer’s Disease Drug Industrial Chain Analysis

Table Raw Materials Sources of Alzheimer’s Disease Drug Major Manufacturers in 2016

Table Major Buyers of Alzheimer’s Disease Drug

Table Distributors/Traders/ Dealers List